Published in Digestion on March 23, 2009
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. World J Gastroenterol (2013) 1.05
Comparison of gastroesophageal reflux disease symptoms and proton pump inhibitor response using gastroesophageal reflux disease impact scale questionnaire. J Neurogastroenterol Motil (2013) 0.87
Overlap of functional dyspepsia and GERD--diagnostic and treatment implications. Nat Rev Gastroenterol Hepatol (2013) 0.84
Gastro oesophageal reflux disease (GORD)-related symptoms and its association with mood and anxiety disorders and psychological symptomology: a population-based study in women. BMC Psychiatry (2013) 0.82
Gastroesophageal reflux disease symptoms and dietary behaviors are significant correlates of short sleep duration in the general population: the Nagahama Study. Sleep (2014) 0.80
Natural history of heartburn: a 10-year population-based study. World J Gastroenterol (2011) 0.78
Non-erosive reflux disease rather than cervical inlet patch involves globus. J Gastroenterol (2010) 0.77
Symptom characteristics and psychosomatic profiles in different spectrum of gastroesophageal reflux disease. Gut Liver (2013) 0.75
Practice pattern of gastroenterologists for the management of GERD under the minimal influence of the insurance reimbursement guideline: a multicenter prospective observational study. J Korean Med Sci (2011) 0.75
Intravitreal bevacizumab for symptomatic retinal arterial macroaneurysm. Am J Ophthalmol (2013) 2.41
Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms. J Gastroenterol Hepatol (2006) 2.04
Diagnostic value of terminal ileum intubation during colonoscopy. J Gastroenterol Hepatol (2008) 2.01
Application of the HALF index obviates the need for liver biopsy in half of all patients with chronic hepatitis B. J Gastroenterol Hepatol (2011) 1.63
Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study. Digestion (2009) 1.57
Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol (2012) 1.47
Long-term lamivudine therapy for chronic hepatitis B in patients with and without cirrhosis. Pharmacotherapy (2002) 1.44
[Factors associated with liver stiffness in chronic liver disease]. Korean J Hepatol (2009) 1.44
Endoscopic resection of ampullary adenoma after a new insulated plastic pancreatic stent placement: a pilot study. J Gastroenterol Hepatol (2010) 1.41
Long-term luminal change after drug-eluting stent implantation: serial angiographic follow-up study of the ZEST randomized trial. Catheter Cardiovasc Interv (2012) 1.40
[Study on association between an H-RAS gene polymorphism and gastric cancer development]. Korean J Gastroenterol (2010) 1.40
[Entecavir therapy for patients with hepatitis B virus-related decompensated cirrhosis]. Korean J Gastroenterol (2012) 1.39
[Relapse rates of ulcerative colitis in remission and factors related to relapse]. Korean J Gastroenterol (2008) 1.39
The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol (2008) 1.38
Longitudinal 2D strain at rest predicts the presence of left main and three vessel coronary artery disease in patients without regional wall motion abnormality. Eur J Echocardiogr (2009) 1.30
Endoscopic resection for the treatment of gastric subepithelial tumors originated from the muscularis propria layer. Hepatogastroenterology (2009) 1.23
Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver Int (2007) 1.21
Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells. Clin Cancer Res (2004) 1.21
Amelioration of pancreatic fibrosis in mice with defective TGF-beta signaling. Pancreas (2005) 1.09
Risk factors for perforations associated with endoscopic submucosal dissection in gastric lesions: emphasis on perforation type. Surg Endosc (2012) 1.09
Comparison of uncovered stent with covered stent for treatment of malignant colorectal obstruction. Gastrointest Endosc (2007) 1.08
Efficacy and tolerability of peginterferon alpha plus ribavirin in the routine daily treatment of chronic hepatitis C patients in Korea: a multi-center, retrospective observational study. Gut Liver (2012) 1.08
Comparison of multiplex restriction fragment mass polymorphism and sequencing analyses for detecting entecavir resistance in chronic hepatitis B. Antivir Ther (2011) 1.07
Rescue of Helicobacter pylori-induced cytotoxicity by red ginseng. Dig Dis Sci (2005) 1.07
A randomized comparative study of high-dose and low-dose hepatic arterial infusion chemotherapy for intractable, advanced hepatocellular carcinoma. Cancer Chemother Pharmacol (2009) 1.06
Y-shaped endoscopic bilateral metal stent placement for malignant hilar biliary obstruction: prospective long-term study. Scand J Gastroenterol (2010) 1.06
G-Protein Beta3 Subunit C825T Polymorphism in Patients With Overlap Syndrome of Functional Dyspepsia and Irritable Bowel Syndrome. J Neurogastroenterol Motil (2012) 1.04
Dynamic left ventricular outflow tract obstruction without basal septal hypertrophy, caused by catecholamine therapy and volume depletion. Korean J Intern Med (2008) 1.04
A genome-wide association study identified new variants associated with the risk of chronic hepatitis B. Hum Mol Genet (2013) 1.02
Effect of virological response on post-treatment durability of lamivudine-induced HBeAg seroconversion. J Viral Hepat (2002) 1.00
Association of interleukin-18 gene polymorphisms with hepatitis B virus clearance. Dig Dis Sci (2009) 1.00
Palliative treatment of malignant gastroduodenal obstruction with metallic stent: prospective comparison of covered and uncovered stents. Scand J Gastroenterol (2009) 1.00
Comparison of surrogate serum markers and transient elastography (Fibroscan) for assessing cirrhosis in patients with chronic viral hepatitis. Dig Dis Sci (2010) 0.99
Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B. Gut Liver (2011) 0.97
Restoration of heat shock protein70 suppresses gastric mucosal inducible nitric oxide synthase expression induced by Helicobacter pylori. Proteomics (2004) 0.97
Outcomes of pregnancy in women with congenital heart disease: a single center experience in Korea. J Korean Med Sci (2008) 0.96
Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: clonal evolution during lamivudine plus adefovir therapy. J Med Virol (2012) 0.95
[A case of Salmonella liver abscess]. Korean J Gastroenterol (2006) 0.94
Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma. Proteomics (2009) 0.94
Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis. Korean J Hepatol (2010) 0.93
The usefulness of liver stiffness measurement using FibroScan in chronic hepatitis C in South Korea: a multicenter, prospective study. J Gastroenterol Hepatol (2011) 0.92
The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells. J Clin Endocrinol Metab (2002) 0.91
Genetic polymorphism of interferon-gamma, interferon-gamma receptor, and interferon regulatory factor-1 genes in patients with hepatitis B virus infection. Biochem Genet (2006) 0.91
How can we predict the presence of missed synchronous lesions after endoscopic submucosal dissection for early gastric cancers or gastric adenomas? J Clin Gastroenterol (2013) 0.91
Pepsin detection in the sputum/saliva for the diagnosis of gastroesophageal reflux disease in patients with clinically suspected atypical gastroesophageal reflux disease symptoms. Digestion (2008) 0.91
Blockage of HSP 90 modulates Helicobacter pylori-induced IL-8 productions through the inactivation of transcriptional factors of AP-1 and NF-kappaB. Biochem Biophys Res Commun (2004) 0.90
Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible? J Biochem Mol Biol (2003) 0.89
Lack of association between hepatitis B virus infection and polymorphism of mannose-binding lectin gene in Korean population. J Korean Med Sci (2005) 0.89
Lymph node metastasis of gastric cancer is associated with the interaction between poly (ADP-ribose) polymerase 1 and matrix metallopeptidase 2. DNA Cell Biol (2011) 0.89
A functional SNP of the Interleukin-18 gene is associated with the presence of hepatocellular carcinoma in hepatitis B virus-infected patients. Dig Dis Sci (2009) 0.89
Correlation of serum hepatitis B surface antigen level with response to entecavir in naïve patients with chronic hepatitis B. J Med Virol (2011) 0.89
Association of polymorphism in MicroRNA 219-1 with clearance of hepatitis B virus infection. J Med Virol (2013) 0.87
Adefovir-based combination therapy with entecavir or lamivudine for patients with entecavir-refractory chronic hepatitis B. J Med Virol (2011) 0.87
Ginseng, the root of Panax ginseng C.A. Meyer, protects ethanol-induced gastric damages in rat through the induction of cytoprotective heat-shock protein 27. Dig Dis Sci (2007) 0.87
Short-term effects of magnetic sacral dermatome stimulation for idiopathic slow transit constipation: sham-controlled, cross-over pilot study. J Gastroenterol Hepatol (2006) 0.87
Loss of transgelin in repeated bouts of ulcerative colitis-induced colon carcinogenesis. Proteomics (2006) 0.87
Relationship of underlying abnormalities in rectal sensitivity and compliance to distension with symptoms in irritable bowel syndrome. Digestion (2006) 0.86
Integrin alpha V polymorphisms and haplotypes in a Korean population are associated with susceptibility to chronic hepatitis and hepatocellular carcinoma. Liver Int (2008) 0.86
Survival benefits of intra-arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis. Hepatol Res (2005) 0.86
Argon plasma coagulation with submucosal saline injection for gastric adenoma on outpatient basis. Dig Dis Sci (2009) 0.86
Polymorphisms near interleukin 28B gene are not associated with hepatitis B virus clearance, hepatitis B e antigen clearance and hepatocellular carcinoma occurrence. Intervirology (2013) 0.85
Amelioration of oxidative stress with ensuing inflammation contributes to chemoprevention of H. pylori-associated gastric carcinogenesis. Antioxid Redox Signal (2004) 0.85
[Development of clevudine resistance after switching from lamivudine in a patient with chronic hepatitis B]. Korean J Gastroenterol (2008) 0.85
RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population. J Korean Med Sci (2007) 0.85
5-LOX inhibitor modulates the inflammatory responses provoked by Helicobacter pylori infection. Helicobacter (2007) 0.84
Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients. Clin Mol Hepatol (2013) 0.84
Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population. BMC Gastroenterol (2013) 0.84
[Association of interleukin-12 gene polymorphism with persistence of hepatitis B virus infection and hepatocellular carcinoma]. Korean J Gastroenterol (2007) 0.83
Retraction: Blockage of intracellular proton extrusion with proton pump inhibitor induces apoptosis in gastric cancer. Cancer Sci (2007) 0.83
A practical scoring system for predicting cirrhosis in patients with chronic viral hepatitis. Hepatogastroenterology (2012) 0.83
[A case of acute cholestatic hepatitis associated with Orlistat]. Taehan Kan Hakhoe Chi (2002) 0.83
Partially covered versus uncovered self-expandable nitinol stents with anti-migration properties for the palliation of malignant distal biliary obstruction: A randomized controlled trial. Scand J Gastroenterol (2015) 0.82
Emergence of adefovir-resistant mutants after reversion to YMDD wild-type in lamivudine-resistant patients receiving adefovir monotherapy. J Gastroenterol Hepatol (2009) 0.82
MicroRNA-196A-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis B. J Med Virol (2013) 0.82
Unilateral scleral fixation of posterior chamber intraocular lenses in pediatric complicated traumatic cataracts. Korean J Ophthalmol (2009) 0.82
Usefulness of multiple biomarkers for the prediction of significant fibrosis in chronic hepatitis B. J Clin Gastroenterol (2011) 0.81
Preoperative left atrial volume index is a predictor of successful sinus rhythm restoration and maintenance after the maze operation. J Thorac Cardiovasc Surg (2007) 0.81
Serum markers for predicting significant necroinflammatory activity in patients with chronic hepatitis B. Clin Biochem (2012) 0.81
Development and validation of a model to predict advanced fibrosis in chronic hepatitis B virus-infected patients with high viral load and normal or minimally raised ALT. Dig Dis Sci (2010) 0.81
Interleukin-1ß and interleukin-1 receptor accessory protein gene polymorphisms are associated with persistent hepatitis B virus infection. Hepatogastroenterology (2012) 0.81
Hemorrhagic complications after intravitreal ranibizumab injection for polypoidal choroidal vasculopathy. Can J Ophthalmol (2012) 0.80
Influence of diabetes mellitus on long-term (five-year) outcomes of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization. Am J Cardiol (2012) 0.80
Non-invasive index for predicting significant liver fibrosis: comparison of diagnostic performances in patients with chronic hepatitis B and C. Dig Dis Sci (2010) 0.80
Effect of preload on left ventricular longitudinal strain by 2D speckle tracking. Echocardiography (2008) 0.80
Association of lamivudine-resistant mutational patterns with the antiviral effect of adefovir in patients with chronic hepatitis B. J Med Virol (2009) 0.80
Association between apolipoprotein E genotype, chronic liver disease, and hepatitis B virus. Clin Mol Hepatol (2012) 0.80
Association of polymorphism in pri-microRNAs-371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patients. PLoS One (2012) 0.80
Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration treated with ranibizumab. Am J Ophthalmol (2012) 0.80
Relevance of interleukin-10RB to chronic hepatitis B virus infection and biological activities of interferon-λ and interleukin-22. Hepatol Int (2012) 0.79
Matrix metalloproteinase-3 genotypes influence recovery from hepatitis B virus infection. J Korean Med Sci (2008) 0.79
[Efficacy of AST to platelet ratio index in predicting severe hepatic fibrosis and cirrhosis in chronic hepatitis B virus infection]. Korean J Gastroenterol (2005) 0.79
Association between Interferon-Inducible Protein 6 (IFI6) Polymorphisms and Hepatitis B Virus Clearance. Genomics Inform (2013) 0.79
[Effect of infliximab in the treatment of refractory inflammatory bowel disease with complication]. Korean J Gastroenterol (2004) 0.79
Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study. Clin Mol Hepatol (2013) 0.79
Development and psychometric evaluation of a chronic liver disease-specific quality of life questionnaire. J Gastroenterol Hepatol (2007) 0.79
Hepatic failure requiring transplantation caused by portal vein embolism as a complication of N-buty-2-cyanoacrylate injection for a bleeding gastric varix. Gastrointest Endosc (2009) 0.79
Loss of SM22 is a characteristic signature of colon carcinogenesis and its restoration suppresses colon tumorigenicity in vivo and in vitro. Cancer (2010) 0.79
Dietary influence on electro-gastrography and association of alterations in gastric myoelectrical activity with symptoms in patients with functional dyspepsia. J Gastroenterol Hepatol (2006) 0.79